Recs

4

4 Stocks That Took a Hike

I love to kick off the new trading week by taking a quick peek at companies that have just hiked their dividends. It's not just about the money. A company that is easing up on its pocketbook probably has improving fundamentals to back up that generosity.

Readers of the Income Investor newsletter can certainly appreciate that kind of thinking. Let's take a closer look at four of the companies that inched their payouts higher over the past few trading days.

Let's start with Bristol-Myers Squibb (NYSE: BMY  ) . The drugmaker came through with an 11% boost to its quarterly distributions. It's the first hike by the company in six years. Now paying $0.31 a share every three months, Bristol-Myers Squibb is yielding a hefty 4.6%. Big Pharma is so out of favor that Pfizer (NYSE: PFE  ) has a monster yield of 5.6% at the moment.

Then we have mutual fund darling Freeport McMoRan (NYSE: FCX  ) mining for more. The copper king gets the metal medal with a 40% increase in its rate. The new $0.4375-a-share quarterly rate is just another treat for investors who have seen their shares soar more than sixfold over the past six years. Mining for copper and gold can be pretty lucrative when the commodity prices remain buoyant.

Kayne Anderson (NYSE: KED  ) is another hiker. The closed-end fund specializing in squeezing income out of energy sector investments is bumping up its dividend by 1%, to $0.41 a share.

Finally, we have Commercial Metals (NYSE: CMC  ) putting the pedal to the metal. The company's new $0.12-a-share rate is 33% higher than the old payout. Investors must be getting used to this, since Commercial Metals has bumped up its dividend four times over the past two years.

Subscribers to the Motley Fool Income Investor newsletter can appreciate the companies sending more and more money to their investors. The newsletter singles out companies that are committed to growing their distributions with market-thumping results.

Want to see what is being recommended these days? Go ahead and give the newsletter service a shot with a free 30-day trial subscription. Who knows? Maybe the next thing that will get hiked will be your interest.

As Foolanthropy enters its second decade, join us in working to bring financial education to the world's children. Learn more about Foolanthropy's new direction.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 557595, ~/Articles/ArticleHandler.aspx, 2/14/2012 7:11:53 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,878.28 4.24 0.03%
S&P 500 1,350.50 -1.27 -0.09%
NASD 2,931.83 0.44 0.02%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 4:02 PM
FCX $42.96 Down -1.70 -3.81%
Freeport-McMoRan C… CAPS Rating: ****
PFE $21.33 Up +0.03 +0.14%
Pfizer, Inc. CAPS Rating: ****
BMY $31.85 Down -0.14 -0.44%
Bristol-Myers Squi… CAPS Rating: ****
CMC $13.67 Down -0.30 -2.15%
Commercial Metals… CAPS Rating: ****

Advertisement